APA (7th ed.) Citation

Denkert, C., Seither, F., Schneeweiss, A., Link, T., Blohmer, J., Just, M., . . . Loibl, S. (2021). Clinical and molecular characteristics of HER2-low-positive breast cancer: Pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. The lancet. Oncology, 22(8), . https://doi.org/10.1016/S1470-2045(21)00301-6

Chicago Style (17th ed.) Citation

Denkert, Carsten, et al. "Clinical and Molecular Characteristics of HER2-low-positive Breast Cancer: Pooled Analysis of Individual Patient Data from Four Prospective, Neoadjuvant Clinical Trials." The Lancet. Oncology 22, no. 8 (2021). https://doi.org/10.1016/S1470-2045(21)00301-6.

MLA (9th ed.) Citation

Denkert, Carsten, et al. "Clinical and Molecular Characteristics of HER2-low-positive Breast Cancer: Pooled Analysis of Individual Patient Data from Four Prospective, Neoadjuvant Clinical Trials." The Lancet. Oncology, vol. 22, no. 8, 2021, https://doi.org/10.1016/S1470-2045(21)00301-6.